Acute Comfort of Lubricant Eye Drop FID 111421

Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT00673959
Collaborator
(none)
20
2

Study Details

Study Description

Brief Summary

To evaluate the acute comfort and blurring profile between two artificial tears products in dry eye patients

Condition or Disease Intervention/Treatment Phase
  • Other: Lubricant Eye Drop FID 111421
  • Other: Optive Lubricant Eye Drop
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Study Start Date :
Dec 1, 2007
Actual Primary Completion Date :
Feb 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lubricant Eye Drop FID 111421

Lubricant Eye Drop FID 111421 1 drop each eye one time

Other: Lubricant Eye Drop FID 111421
Lubricant Eye Drop FID 111421 1 drop each eye one time

Active Comparator: Optive Lubricant Eye Drop

Optive Lubricant Eye Drop 1 drop each eye one time

Other: Optive Lubricant Eye Drop
Optive Lubricant Eye Drop 1 drop each eye one time

Outcome Measures

Primary Outcome Measures

  1. Drop Comfort Upon Instillation [upon instillation]

    Drop comfort grading scale is a scale from 0 to 9, with 0 meaning most comfortable and 9 meaning most uncomfortable.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Documented diagnosis of dry eye

  • Must not have worn contact lenses for 1 week preceding enrollment

Exclusion Criteria:
  • Age related

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Alcon Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alcon Research
ClinicalTrials.gov Identifier:
NCT00673959
Other Study ID Numbers:
  • C-07-08
First Posted:
May 7, 2008
Last Update Posted:
Feb 2, 2012
Last Verified:
Jan 1, 2012
Keywords provided by Alcon Research
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details 20 Dry Eye Subjects
Pre-assignment Detail Randomized, double-masked, crossover
Arm/Group Title Lubricant Drops, Then Optive Drops Optive Drops, Then Lubricant Drops
Arm/Group Description Patients received Lubricant Drops first, then received Optive Drops Patients received Optive Drops first, then received Lubricant Drops
Period Title: Overall Study
STARTED 10 10
COMPLETED 10 10
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Overall Study
Arm/Group Description
Overall Participants 20
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
17
85%
>=65 years
3
15%
Sex: Female, Male (Count of Participants)
Female
16
80%
Male
4
20%

Outcome Measures

1. Primary Outcome
Title Drop Comfort Upon Instillation
Description Drop comfort grading scale is a scale from 0 to 9, with 0 meaning most comfortable and 9 meaning most uncomfortable.
Time Frame upon instillation

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Lubricant Eye Drop FID 111421 Optive Lubricant Eye Drop
Arm/Group Description
Measure Participants 20 20
Mean (Standard Deviation) [Units on a scale]
1.7
(1.8)
1.3
(1.4)

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Lubricant Eye Drop FID 111421 Optive Lubricant Eye Drop
Arm/Group Description
All Cause Mortality
Lubricant Eye Drop FID 111421 Optive Lubricant Eye Drop
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Lubricant Eye Drop FID 111421 Optive Lubricant Eye Drop
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%)
Other (Not Including Serious) Adverse Events
Lubricant Eye Drop FID 111421 Optive Lubricant Eye Drop
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

The PI should hold confidential, and not disclose directly or indirectly to any third party onther than Contractors, the data arising out of the study.

Results Point of Contact

Name/Title Alcon Clinical
Organization Alcon Research, Ltd.
Phone 888.451.3937; 817.568.6725
Email medinfo@alconlabs.com
Responsible Party:
Alcon Research
ClinicalTrials.gov Identifier:
NCT00673959
Other Study ID Numbers:
  • C-07-08
First Posted:
May 7, 2008
Last Update Posted:
Feb 2, 2012
Last Verified:
Jan 1, 2012